Clinical Trial

Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 23, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
In the case of large tumors or tumors closely adjacent to organs at risk, ablative doses offered by stereotactic body radiation therapy (SBRT) could not be delivered. Therefore, a technique that could provide high radiation doses to tumors without increasing of risks of severe adverse effects is required.
Trial Details
NCT Number NCT06427460
Lead Sponsor Changhai Hospital
Conditions Pancreatic Cancer
Enrollment 67 participants
Start Date 2024-05-12
Primary Completion 2025-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-23